Recent QURE News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:48:04 AM
- uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease • GlobeNewswire Inc. • 08/15/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/01/2024 12:54:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:51:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:43:22 AM
- uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update • GlobeNewswire Inc. • 08/01/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 11:10:32 AM
- uniQure Announces Closing of Sale of Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/23/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 11:13:10 AM
- uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease • GlobeNewswire Inc. • 07/09/2024 11:05:00 AM
- uniQure Announces Sale of Commercial Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/01/2024 11:05:00 AM
- Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA • PR Newswire (US) • 07/01/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:53:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:49:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 10:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:46:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:40:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:24:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:42:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:18:51 AM
- uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease • GlobeNewswire Inc. • 06/03/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:03:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 11:57:14 AM
- uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 05/07/2024 11:05:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM